Renal oncocytoma: landscape of diagnosis and management
Open Access
- 26 May 2021
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 128 (6) , 685-687
Abstract
Renal oncocytoma represents between 6-12% of T1 renal tumours in surgical series (1–2). Contemporary imaging cannot differentiate oncocytoma from malignant renal cell carcinoma (RCC). Uptake of renal tumour biopsy in clinical practice has been variable (3) and surgery with partial or radical nephrectomy is the first-line in the management of RCC (4,5). Therefore, many patients with renal masses undergo empirical surgery for presumed RCC with post-operative histologic diagnosis of benign oncocytoma.Keywords
This publication has 11 references indexed in Scilit:
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 UpdateEuropean Urology, 2019
- Contemporary surgical management of renal oncocytoma: a nation's outcomeBJU International, 2018
- Renal Mass and Localized Renal Cancer: AUA GuidelineJournal of Urology, 2017
- Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT/CTEJNMMI Research, 2017
- Renal Mass Biopsy: Always, Sometimes, or Never?European Urology, 2016
- Active surveillance is suitable for intermediate term follow‐up of renal oncocytoma diagnosed by percutaneous core biopsyBJU International, 2016
- Prospective Evaluation of 99mTc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe TumorsEuropean Urology, 2016
- A Preoperative Prognostic Nomogram for Solid Enhancing Renal Tumors 7 cm or Less Amenable to Partial NephrectomyJournal of Urology, 2007
- Incidence of Benign Lesions for Clinically Localized Renal Masses Smaller Than 7 cm in Radiological Diameter: Influence of SexJournal of Urology, 2006
- Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsyUrology, 2005